The scientist’s investigation covers issues in Pathology, Lymphoma, Cancer research, Internal medicine and Immunophenotyping. Pathology is frequently linked to Leukemia in his study. He interconnects Biopsy and Germinal center in the investigation of issues within Lymphoma.
His research on Cancer research also deals with topics like
L. Jeffrey Medeiros mainly investigates Pathology, Lymphoma, Internal medicine, Cancer research and Oncology. L. Jeffrey Medeiros has included themes like Leukemia, Myeloid leukemia and Immunophenotyping in his Pathology study. His Lymphoma study is associated with Immunology.
L. Jeffrey Medeiros has researched Internal medicine in several fields, including Gastroenterology and Surgery. His study in Cancer research is interdisciplinary in nature, drawing from both Chronic lymphocytic leukemia and B cell. His Diffuse large B-cell lymphoma study combines topics from a wide range of disciplines, such as CHOP and Germinal center.
His main research concerns Internal medicine, Cancer research, Pathology, Lymphoma and Oncology. While the research belongs to areas of Internal medicine, L. Jeffrey Medeiros spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Myelofibrosis and Stage. The Cancer research study combines topics in areas such as Anaplastic lymphoma kinase and Immunotherapy.
His Pathology study frequently draws connections to other fields, such as Gene rearrangement. His Lymphoma research incorporates themes from Immunophenotyping and B cell. L. Jeffrey Medeiros interconnects Fluorescence in situ hybridization, Radiation therapy and Philadelphia chromosome in the investigation of issues within Oncology.
L. Jeffrey Medeiros mostly deals with Lymphoma, Internal medicine, Pathology, Cancer research and Oncology. His studies in Lymphoma integrate themes in fields like Large cell and B cell. His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.
He regularly links together related areas like Immunophenotyping in his Pathology studies. His Cancer research research integrates issues from Protein kinase B, Pathogenesis, Ibrutinib, Prognostic factor and Immunotherapy. He has included themes like Cytarabine, Myeloid leukemia, Complex Karyotype and Germinal center in his Oncology study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Heidelberg classification of renal cell tumours
Gyula Kovacs;Mohammed Akhtar;Bruce J. Beckwith;Peter Bugert.
The Journal of Pathology (1997)
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
Jorge E. Romaguera;Luis Fayad;Maria A. Rodriguez;Kristine R. Broglio.
Journal of Clinical Oncology (2005)
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu;Zijun Y. Xu-Monette;Alexander Tzankov;Tina Green.
Timothy C. Greiner;L. Jeffrey Medeiros;Elaine S. Jaffe.
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Adam M Petrich;Mitul Gandhi;Borko Jovanovic;Jorge J Castillo.
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
Issa F Khouri;Peter McLaughlin;Rima M Saliba;Chitra Hosing.
Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda;Tariq N. Aladily;H. Miles Prince;Rashmi Kanagal-Shamanna.
Journal of Clinical Oncology (2014)
Frequent presence of the epstein-barr virus in inflammatory pseudotumor
Daniel A Arber;Onsi W Kamel;Matt van de Rijn;R.Eric Davis.
Human Pathology (1995)
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
Yasuhiro Oki;Mansoor Noorani;Pei Lin;Richard E. Davis.
British Journal of Haematology (2014)
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Mark W. Clemens;L. Jeffrey Medeiros;Charles E. Butler;Kelly K. Hunt.
Journal of Clinical Oncology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: